+91-22-62820123
Table of Contents
- Why to Invest in Mutual Funds?
- Best Equity Mutual Funds 2022 - 2023
- Best Debt Funds 2022 - 2023
- Best Hybrid Funds 2022 - 2023
- Top 5 Gold Funds 2022 - 2023
- Best Mutual Funds Based on 1 Month Performance
- How to Invest in Best Mutual Funds Online?
- Smart Tips to Invest in Best Mutual Funds: Lump Sum & SIP Investments
Top 5 Funds
Best Performing Mutual Funds 2022 - 2023
Mutual Funds in India have grown over the years. As a result, the best performing funds in the Market keep on changing. There are various rating systems in place to judge MF schemes, such as CRISIL, Morning Star, ICRA. These systems evaluate funds based on qualitative and quantitative factors such as returns, asset size, expense ratio, Standard Deviation, etc.
The summation of all these factors leads to the rating of the best performing mutual funds in India. However, to make the process of Investing easier for investors, we have shortlisted the best performing mutual funds in India along with guidelines to choose the best fund.
Why to Invest in Mutual Funds?
Investing in mutual funds don't just hold one benefit, it comes with multiple advantages that help investors grow their money. It fulfills short-, mid- and long-term investment goals. There are various fund options you can pick to invest, right from low-risk to high-risk schemes like debt and Equity Funds.
One of the important features that draw people's attention to mutual funds is the minimum investment amount. You can start investing in a SIP in just INR 500.
Let's look at some more reasons on why you should invest in Mutual Funds:
1. Liquidity
In open-ended schemes, it is easy to buy and exit a scheme. One can sell your units at any point (it is ideally suggested when markets are high). But, when you invest in a fund, you should know the exit load charges. In mutual funds, the transaction happens a day after the fund house releases that day’s Net Asset Value (NAV).
2. Diversification
The mutual fund holds various financial instruments such as stocks, fixed Income instruments, gold, etc. Due to which, you can enjoy the benefits of diversification by investing in just one scheme. On the contrary, if individuals choose to directly invest in shares they need to research stocks of various companies before putting money.
3. Well-Regulated
The mutual fund industry in India is well-regulated by SEBI (The Securities and Exchange Board of India). It keeps a check on the functioning of all the mutual funds. In addition, these fund houses are also transparent wherein; they need to publish their performance reports at regular intervals.
4. Expert Management
Each MF scheme is managed by a dedicated fund manager. The fund manager’s objective is to ensure that the investors earn maximum returns from the scheme by keeping a constant watch on the performance and changing the Asset Allocation timely as per the market requirements.
Talk to our investment specialist
Best Equity Mutual Funds 2022 - 2023
Below are the top ranked funds from difference categories of equity funds like large-, mid-, small-, multi-cap, ELSS and sectoral funds.
Top 5 Large Cap Equity Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) Canara Robeco Bluechip Equity Fund Growth ₹40.69
↑ 0.86 ₹8,056 9.2 -2.8 -3.3 17.7 13.5 24.5 Nippon India Large Cap Fund Growth ₹53.3185
↑ 1.17 ₹12,193 12.3 1.8 5.2 17.7 12 32.4 IDBI India Top 100 Equity Fund Growth ₹39.22
↑ 0.86 ₹624 10.5 -3 -1.9 17.6 10.6 31.2 ICICI Prudential Bluechip Fund Growth ₹66.21
↑ 1.26 ₹33,739 9 -2 1.7 17.2 11.9 29.2 Kotak Bluechip Fund Growth ₹369.781
↑ 7.28 ₹4,997 9 -2.6 -3 17.1 11.9 27.7 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Mid Cap Equity Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) PGIM India Midcap Opportunities Fund Growth ₹45.01
↑ 0.96 ₹6,614 15.8 4.2 5.2 38.8 19.3 63.8 Axis Mid Cap Fund Growth ₹68.6
↑ 1.22 ₹19,504 13 0.9 -1.3 22.4 17.2 39.9 Kotak Emerging Equity Scheme Growth ₹76.225
↑ 1.17 ₹21,935 15 4.7 6.5 27.1 15.4 47.3 Motilal Oswal Midcap 30 Fund Growth ₹51.5724
↑ 0.77 ₹3,158 21.8 14.3 21.5 27.5 15.3 55.8 Edelweiss Mid Cap Fund Growth ₹52.665
↑ 1.00 ₹2,256 15.6 4.4 4.6 27.6 15.2 50.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Small Cap Equity Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) Nippon India Small Cap Fund Growth ₹91.1395
↑ 1.18 ₹21,655 16 4.1 10.3 35.6 18.3 74.3 SBI Small Cap Fund Growth ₹115.13
↑ 0.99 ₹14,044 18.3 9.8 12.5 31.2 17.9 47.6 Kotak Small Cap Fund Growth ₹166.546
↑ 1.49 ₹8,356 12.5 0.4 2.5 34.2 17.9 70.9 ICICI Prudential Smallcap Fund Growth ₹53.85
↑ 0.40 ₹4,138 10.4 4.4 6.3 30.8 15.4 61 HDFC Small Cap Fund Growth ₹76.783
↑ 1.30 ₹13,797 17 4.5 2.9 26.5 14.8 64.9 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Diversified/Multi-Cap Equity Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) PGIM India Diversified Equity Fund Growth ₹24.86
↑ 0.39 ₹5,081 9.7 -5.9 -7.4 24.3 14.3 43.5 Mahindra Badhat Yojana Growth ₹20.5669
↑ 0.41 ₹1,388 12.6 -2.8 -0.5 24.3 14.5 50.8 Parag Parikh Long Term Equity Fund Growth ₹47.3826
↑ 0.83 ₹25,996 6.9 -6.8 -4.9 24 16.5 45.5 Nippon India Multi Cap Fund Growth ₹164.91
↑ 3.14 ₹13,224 17.2 6.1 12.3 22.1 13.8 48.9 Principal Multi Cap Growth Fund Growth ₹239.387
↑ 3.93 ₹1,903 12.6 -1.3 2 21.9 12 46.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 (ELSS) Equity Linked Saving Schemes
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) BOI AXA Tax Advantage Fund Growth ₹98.98
↑ 2.10 ₹645 14.1 -0.3 -3.1 24.7 14.3 41.5 IDFC Tax Advantage (ELSS) Fund Growth ₹98.71
↑ 1.80 ₹3,851 12 -1.5 3 24.2 13 49.2 Canara Robeco Equity Tax Saver Growth ₹115.67
↑ 2.49 ₹4,197 11.8 -0.5 -0.3 22.1 15.7 35.1 Mirae Asset Tax Saver Fund Growth ₹30.332
↑ 0.55 ₹13,148 7.7 -3.8 -3.4 20.9 14.5 35.3 HDFC Long Term Advantage Fund Growth ₹595.168
↑ 0.28 ₹1,318 1.2 15.4 35.5 20.6 17.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Sector Equity Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) ICICI Prudential Technology Fund Growth ₹129.61
↑ 2.87 ₹8,712 0.1 -20.6 -18 30.2 25.9 75.7 Aditya Birla Sun Life Digital India Fund Growth ₹112.44
↑ 2.59 ₹3,135 1.9 -19.4 -16.8 28.1 25 70.5 Nippon India Pharma Fund Growth ₹287.81
↑ 2.66 ₹4,588 9.6 -2.3 -8.9 27.5 17.2 23.9 SBI Healthcare Opportunities Fund Growth ₹220.755
↑ 1.80 ₹1,675 10.2 -1.4 -7.1 27.4 12.2 20.1 TATA Digital India Fund Growth ₹30.5719
↑ 0.68 ₹5,981 0.8 -20.8 -17.9 27.1 26.2 74.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Value Equity Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) IDFC Sterling Value Fund Growth ₹91.112
↑ 1.52 ₹4,906 12.9 0.9 7 26.8 11.7 64.5 ICICI Prudential Value Discovery Fund Growth ₹260.82
↑ 4.35 ₹25,576 9.8 0.1 5.3 24.2 13.9 38.5 Templeton India Value Fund Growth ₹428.51
↑ 7.30 ₹757 13.4 4 7.8 24.1 10.6 44.5 Nippon India Value Fund Growth ₹124.392
↑ 2.73 ₹4,714 12.2 -1.5 0.6 20.8 12.4 39.4 UTI Value Opportunities Fund Growth ₹100.923
↑ 1.67 ₹6,923 11 -0.4 0.3 19.9 12.8 30.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Focused Equity Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) Nippon India Focused Equity Fund Growth ₹79.9256
↑ 1.75 ₹6,193 9.9 0.4 2.9 22.4 12.4 36.6 IIFL Focused Equity Fund Growth ₹29.5438
↑ 0.53 ₹3,269 12.6 -1.6 -1.6 21.2 15.4 36.4 Franklin India Focused Equity Fund Growth ₹68.3922
↑ 1.36 ₹8,184 12.6 2.2 4 21.2 13.4 39.4 ICICI Prudential Focused Equity Fund Growth ₹49.73
↑ 0.84 ₹3,657 9.5 -0.7 0 20.6 12.8 36.1 Principal Focused Multicap Fund Growth ₹107.642
↑ 2.24 ₹756 12.2 -4.2 -2.2 19.9 13.1 33.7 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Best Debt Funds 2022 - 2023
Below are the top ranked funds from difference categories like. Liquid, Ultra Short, Short Term, GILT, Credit Risk and Corporate Debt from Debt.
Top 5 Ultra Short Term Debt Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 2021 (%) Debt Yield (YTM) Mod. Duration Eff. Maturity Nippon India Ultra Short Duration Fund Growth ₹3,349.5
↑ 0.77 ₹4,931 1.2 2.1 4.1 5.9 7.8 6.46% 4M 12D 5M 1D UTI Ultra Short Term Fund Growth ₹3,526.52
↑ 1.06 ₹2,287 1.2 1.9 3.7 5.2 6.1 6.23% 4M 7D 4M 12D ICICI Prudential Ultra Short Term Fund Growth ₹22.8921
↑ 0.01 ₹14,808 1.2 2.1 3.9 5.2 4 6.28% 3M 22D 4M 10D Aditya Birla Sun Life Savings Fund Growth ₹449.618
↑ 0.18 ₹14,508 1.3 2.1 4.1 5.3 3.9 6.63% 5M 12D 5M 19D SBI Magnum Ultra Short Duration Fund Growth ₹4,939.07
↑ 1.42 ₹11,984 1.2 1.9 3.8 4.6 3.4 6.08% 3M 29D 4M 17D Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Short Term Debt Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 2021 (%) Debt Yield (YTM) Mod. Duration Eff. Maturity UTI Short Term Income Fund Growth ₹25.9591
↑ 0.01 ₹2,174 1.4 1.4 3.1 7.7 8.4 6.89% 2Y 4M 2D 4Y 1M 17D IDBI Short Term Bond Fund Growth ₹22.6374
↑ 0.01 ₹32 1.3 0.6 2.3 7.3 12.1 6.66% 1Y 5M 8D 1Y 9M 11D ICICI Prudential Short Term Fund Growth ₹48.9369
↑ 0.05 ₹15,615 2.1 2.5 3.7 6.6 3.9 6.83% 1Y 6M 4Y 11M 23D BNP Paribas Short Term Fund Growth ₹25.4771
↓ -0.01 ₹258 0.6 1.3 4.6 6.5 5.16% 1Y 11M 26D 2Y 3M HDFC Short Term Debt Fund Growth ₹25.9903
↑ 0.02 ₹13,619 1.4 1.2 2.6 6.3 3.9 6.83% 1Y 9M 18D 2Y 10M 13D Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Liquid Funds
Fund NAV Net Assets (Cr) 1 MO (%) 3 MO (%) 6 MO (%) 1 YR (%) 2021 (%) Debt Yield (YTM) Mod. Duration Eff. Maturity Baroda Pioneer Liquid Fund Growth ₹2,490.27
↑ 0.39 ₹6,432 0.5 1.3 2.4 4.2 3.3 5.75% 29D 1M 2D Mirae Asset Cash Management Fund Growth ₹2,269.49
↑ 0.35 ₹5,128 0.4 1.3 2.3 4.1 3.3 5.72% 1M 13D 1M 13D Axis Liquid Fund Growth ₹2,406.62
↑ 0.40 ₹29,263 0.5 1.3 2.3 4.2 3.3 5.7% 30D 1M 1D UTI Liquid Cash Plan Growth ₹3,549.72
↑ 0.56 ₹32,857 0.5 1.3 2.3 4.1 3.3 5.66% 28D 28D SBI Liquid Fund Growth ₹3,387.95
↑ 0.56 ₹65,441 0.4 1.3 2.3 4.1 3.3 5.67% 1M 10D 1M 13D Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 5 Oct 22
Top 5 Banking and PSU Debt Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 2021 (%) Debt Yield (YTM) Mod. Duration Eff. Maturity ICICI Prudential Banking and PSU Debt Fund Growth ₹26.7219
↑ 0.02 ₹8,186 2.1 2.4 3.5 6.3 4.2 6.56% 1Y 8M 8D 6Y 8M 8D Kotak Banking and PSU Debt fund Growth ₹53.4528
↑ 0.03 ₹6,968 1.7 1.2 2.7 6.2 3.9 6.88% 1Y 8M 26D 4Y 4M 28D IDFC Banking & PSU Debt Fund Growth ₹20.2701
↑ 0.01 ₹15,787 1.2 1.2 2.9 6.2 3.4 6.28% 6M 22D 7M 6D Aditya Birla Sun Life Banking & PSU Debt Fund Growth ₹300.027
↑ 0.16 ₹9,611 1.2 1.2 2.8 6.2 3.6 6.74% 1Y 8M 23D 2Y 5M 8D HDFC Banking and PSU Debt Fund Growth ₹18.8473
↑ 0.01 ₹5,380 1.3 1.1 2.6 6.1 3.7 6.51% 1Y 4M 20D 2Y 5M 23D Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Credit Risk Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 2021 (%) Debt Yield (YTM) Mod. Duration Eff. Maturity BOI AXA Credit Risk Fund Growth ₹10.4147
↑ 0.00 ₹166 1.1 1.3 141 14.3 9.4 6.33% 1Y 14D 1Y 2M 8D Baroda Pioneer Credit Risk Fund Growth ₹18.0198
↑ 0.00 ₹202 1.8 1.6 4.1 8.3 19.2 7.47% 1Y 7M 10D 2Y 29D HDFC Credit Risk Debt Fund Growth ₹19.6678
↑ 0.02 ₹8,700 1.6 1 3.1 7.4 7 8.07% 2Y 29D 2Y 8M 16D ICICI Prudential Regular Savings Fund Growth ₹25.6461
↑ 0.02 ₹8,014 1.5 1.9 4.4 7.4 6.2 8.08% 1Y 5M 19D 2Y 5M 5D Aditya Birla Sun Life Credit Risk Fund Growth ₹16.8941
↑ 0.01 ₹1,225 4 4.2 6.4 6.4 6.4 7.76% 1Y 9M 7D 2Y 9M 4D Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Corporate Bond Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 2021 (%) Debt Yield (YTM) Mod. Duration Eff. Maturity Aditya Birla Sun Life Corporate Bond Fund Growth ₹91.3218
↑ 0.10 ₹13,769 1.6 1.3 3.1 6.7 4 7.06% 1Y 5M 12D 2Y 4M 10D ICICI Prudential Corporate Bond Fund Growth ₹24.207
↑ 0.02 ₹15,495 2.1 2.4 3.6 6.5 4.1 6.87% 11M 5D 4Y 8M 19D HDFC Corporate Bond Fund Growth ₹26.3509
↑ 0.02 ₹21,578 1.7 0.8 2.3 6.3 3.9 6.73% 2Y 4M 10D 4Y 8M 19D Sundaram Corporate Bond Fund Growth ₹33.004
↑ 0.01 ₹1,039 1.2 1.2 2.8 6.2 3.5 6.54% 8M 3D 8M 22D L&T Triple Ace Bond Fund Growth ₹59.5063
↑ 0.09 ₹6,963 1.4 -0.2 0.9 6.2 3.8 7.2% 4Y 7M 2D 6Y 25D Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 GILT Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 2021 (%) Debt Yield (YTM) Mod. Duration Eff. Maturity ICICI Prudential Gilt Fund Growth ₹82.7925
↑ 0.13 ₹2,395 3.3 2.7 2.6 6.7 3.8 5.86% 1Y 5M 23D 9Y 8M 23D Edelweiss Government Securities Fund Growth ₹20.0098
↑ 0.07 ₹109 1.5 0.9 1.2 6.2 4.1 6.66% 4Y 6M 25D 6Y 11M 12D SBI Magnum Gilt Fund Growth ₹53.1742
↑ 0.08 ₹3,670 1.7 1.9 2.8 6.2 3 7.2% 6Y 10M 6D 10Y 5M 5D DSP BlackRock Government Securities Fund Growth ₹77.1078
↑ 0.16 ₹409 1.5 1.1 1.6 6 3.1 6.6% 4Y 2M 16D 6Y 18D Axis Gilt Fund Growth ₹20.646
↑ 0.05 ₹126 1.7 1.2 1.4 5.9 2.4 6.85% 3Y 1M 17D 6Y 3M 18D Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Best Hybrid Funds 2022 - 2023
Below are the top ranked funds from difference categories like. Aggresive, Conservative, Arbitrage, Dynamic Allocation, Multi Asset, Equity Savings and solution oriented Hybrid schemes.
Top 5 Balanced Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) BOI AXA Mid and Small Cap Equity and Debt Fund Growth ₹22.72
↑ 0.32 ₹364 13 -3.4 -1.4 25.6 11.7 54.5 ICICI Prudential Equity and Debt Fund Growth ₹231.93
↑ 2.79 ₹20,360 8.5 0.5 7.3 21.8 13.9 41.7 ICICI Prudential Multi-Asset Fund Growth ₹454.527
↑ 5.21 ₹14,227 8.3 2.5 10.6 20.9 13.5 34.7 Kotak Equity Hybrid Fund Growth ₹40.698
↑ 0.51 ₹2,908 8.1 0.2 3.2 18 11.9 28.9 HDFC Balanced Advantage Fund Growth ₹306.779
↑ 4.92 ₹48,055 9.1 4.7 9.1 17.6 11.5 26.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Aggressive Hybrid Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) BOI AXA Mid and Small Cap Equity and Debt Fund Growth ₹22.72
↑ 0.32 ₹364 13 -3.4 -1.4 25.6 11.7 54.5 ICICI Prudential Equity and Debt Fund Growth ₹231.93
↑ 2.79 ₹20,360 8.5 0.5 7.3 21.8 13.9 41.7 Kotak Equity Hybrid Fund Growth ₹40.698
↑ 0.51 ₹2,908 8.1 0.2 3.2 18 11.9 28.9 UTI Hybrid Equity Fund Growth ₹254.143
↑ 4.07 ₹4,448 7.5 0.2 1.7 17.1 9.3 30.5 Sundaram Equity Hybrid Fund Growth ₹135.137
↑ 0.78 ₹1,954 0.5 10.5 27.1 16 14.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Conservative Hybrid Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) BOI AXA Mid and Small Cap Equity and Debt Fund Growth ₹22.72
↑ 0.32 ₹364 13 -3.4 -1.4 25.6 11.7 54.5 ICICI Prudential Equity and Debt Fund Growth ₹231.93
↑ 2.79 ₹20,360 8.5 0.5 7.3 21.8 13.9 41.7 ICICI Prudential Multi-Asset Fund Growth ₹454.527
↑ 5.21 ₹14,227 8.3 2.5 10.6 20.9 13.5 34.7 Kotak Equity Hybrid Fund Growth ₹40.698
↑ 0.51 ₹2,908 8.1 0.2 3.2 18 11.9 28.9 HDFC Balanced Advantage Fund Growth ₹306.779
↑ 4.92 ₹48,055 9.1 4.7 9.1 17.6 11.5 26.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Arbitrage Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) Kotak Equity Arbitrage Fund Growth ₹30.8501
↓ -0.03 ₹23,310 1.1 2.1 4.1 4.2 5 4 Invesco India Arbitrage Fund Growth ₹26.3068
↓ -0.02 ₹1,530 1.2 2.3 4.4 4.2 4.9 3.5 Edelweiss Arbitrage Fund Growth ₹16.0246
↓ -0.01 ₹5,841 1 1.9 3.9 4.1 5 3.8 L&T Arbitrage Opportunities Fund Growth ₹15.784
↓ -0.02 ₹2,573 1 1.7 3.4 4.1 4.9 3.7 UTI Arbitrage Fund Growth ₹28.9488
↓ -0.02 ₹4,422 1 1.8 3.6 4 4.9 3.9 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Dynamic Allocation Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) HDFC Balanced Advantage Fund Growth ₹306.779
↑ 4.92 ₹48,055 9.1 4.7 9.1 17.6 11.5 26.4 Edelweiss Balanced Advantage Fund Growth ₹35.95
↑ 0.43 ₹8,733 6.6 -1 0 15.2 10.8 18.8 ICICI Prudential Balanced Advantage Fund Growth ₹51.64
↑ 0.41 ₹42,930 5.5 3.1 6.1 12.9 10 15.1 Aditya Birla Sun Life Balanced Advantage Fund Growth ₹73.9
↑ 0.74 ₹6,907 5.9 0.3 0.5 11.9 8.1 13.4 Nippon India Balanced Advantage Fund Growth ₹125.075
↑ 0.99 ₹6,519 6.3 2.1 2.4 11.7 8.6 15.7 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Multi Asset Allocation Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) ICICI Prudential Multi-Asset Fund Growth ₹454.527
↑ 5.21 ₹14,227 8.3 2.5 10.6 20.9 13.5 34.7 Edelweiss Multi Asset Allocation Fund Growth ₹39.36
↑ 0.68 ₹312 9 0 3.9 16.1 11.1 27.1 HDFC Multi-Asset Fund Growth ₹48.269
↑ 0.61 ₹1,595 4.8 -0.2 2.9 15 9.9 17.9 Axis Triple Advantage Fund Growth ₹29.2973
↑ 0.49 ₹1,817 7.8 -4.8 -4.8 13 10.5 22.8 SBI Multi Asset Allocation Fund Growth ₹38.5157
↑ 0.50 ₹588 7 2 3 11.4 8.9 13 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Equity Savings Funds
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) Principal Equity Savings Fund Growth ₹51.277
↑ 0.50 ₹390 4.9 0.9 3.6 12.6 8.7 18.2 L&T Equity Savings Fund Growth ₹23.375
↑ 0.11 ₹192 4.1 0.1 2.8 10.8 7.1 16.1 HDFC Equity Savings Fund Growth ₹49.309
↑ 0.35 ₹2,611 4.7 0.8 3.2 10.6 7.7 16.8 SBI Equity Savings Fund Growth ₹17.6535
↑ 0.16 ₹2,443 5.9 0.6 2.9 10.5 7.7 13.2 Kotak Equity Savings Fund Growth ₹18.9975
↑ 0.11 ₹1,972 3.7 1.4 5.5 9.8 8 11.1 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Solution Oriented Schemes
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) HDFC Retirement Savings Fund - Equity Plan Growth ₹30.176
↑ 0.51 ₹2,414 10.6 3.2 4 22.6 13.7 42.5 HDFC Retirement Savings Fund - Hybrid - Equity Plan Growth ₹25.323
↑ 0.33 ₹883 6.7 0.6 0.8 15.6 11 24.6 Axis Childrens Gift Fund - Compulsory Lock-In Growth ₹19.6163
↑ 0.27 ₹719 8.9 -5.2 -4.4 12.9 10.2 26.7 ICICI Prudential Child Care Plan (Gift) Growth ₹198.33
↑ 2.45 ₹879 8.7 0.5 2.6 14.1 9.5 24.8 Tata Retirement Savings Fund - Progressive Growth ₹42.3141
↑ 0.75 ₹1,293 10.6 0.1 -5 13.5 9 23.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Top 5 Gold Funds 2022 - 2023
Fund NAV Net Assets (Cr) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2021 (%) Axis Gold Fund Growth ₹15.5932
↑ 0.27 ₹263 -1.8 0 9.2 9.6 11.1 -4.7 SBI Gold Fund Growth ₹15.5841
↑ 0.24 ₹1,163 -1.6 -0.3 9.3 9.3 10.4 -5.7 Invesco India Gold Fund Growth ₹15.1468
↑ 0.22 ₹58 -2.9 -1.1 8.6 9.1 10.3 -5.5 HDFC Gold Fund Growth ₹16.0069
↑ 0.31 ₹1,359 -1.6 -1 9.2 9.1 10.3 -5.5 ICICI Prudential Regular Gold Savings Fund Growth ₹16.5398
↑ 0.27 ₹696 -1.5 -0.8 9 9.1 10.3 -5.4 Nippon India Gold Savings Fund Growth ₹20.5362
↑ 0.42 ₹1,427 -1.5 -0.6 9 9 10.2 -5.5 Kotak Gold Fund Growth ₹20.6741
↑ 0.39 ₹1,318 -1.6 -1 8.4 8.9 10.7 -4.7 Aditya Birla Sun Life Gold Fund Growth ₹15.3433
↑ 0.10 ₹261 -2.2 -2.6 7.1 8.9 9.9 -5 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 4 Oct 22
Best Mutual Funds Based on 1 Month Performance
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on "The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in units of MLIIF - WGF. The Scheme may, at the discretion of the Investment Manager, also invest in the units of other similar overseas mutual fund schemes, which may constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or units of money market/liquid schemes of DSP Merrill Lynch Mutual Fund, in order to meet liquidity requirements from time to time. However, there is no assurance that the investment objective of the Scheme will be realized." DSP BlackRock World Gold Fund is a Equity - Global fund was launched on 14 Sep 07. It is a fund with High risk and has given a Below is the key information for DSP BlackRock World Gold Fund Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on To generate long term capital appreciation from a portfolio that is predominantly in equity and equity related instruments HDFC Long Term Advantage Fund is a Equity - ELSS fund was launched on 2 Jan 01. It is a fund with Moderately High risk and has given a Below is the key information for HDFC Long Term Advantage Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on 1. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 8.1% since its launch. Return for 2021 was 19.1% , 2020 was 64.4% and 2019 was 5.5% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (04 Oct 22) ₹16.9354 ↑ 0.12 (0.70 %) Net Assets (Cr) ₹519 on 31 Aug 22 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 2.2 Sharpe Ratio -1.04 Information Ratio 0.6 Alpha Ratio -1.79 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 17 ₹10,000 30 Sep 18 ₹11,166 30 Sep 19 ₹10,785 30 Sep 20 ₹16,637 30 Sep 21 ₹21,824 30 Sep 22 ₹20,368 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Oct 22 Duration Returns 1 Month 5% 3 Month 9.2% 6 Month -2.1% 1 Year -7.1% 3 Year 24.8% 5 Year 14.9% 10 Year 15 Year Since launch 8.1% Historical performance (Yearly) on absolute basis
Year Returns 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 2014 2013 2012 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 1.48 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Aug 22
Equity Sector Allocation
Sector Value Health Care 98.03% Financial Services 1.12% Asset Allocation
Asset Class Value Cash 0.85% Equity 99.15% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA16% ₹81 Cr 912,100 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | 50012412% ₹64 Cr 151,200
↑ 3,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 50008712% ₹63 Cr 605,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP7% ₹36 Cr 84,300 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM6% ₹31 Cr 103,049 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328436% ₹30 Cr 1,005,100 Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5244946% ₹29 Cr 317,452 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002574% ₹22 Cr 323,000 J.B. Chemicals & Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Sep 20 | 5069434% ₹18 Cr 103,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA3% ₹14 Cr 255,000 2. DSP BlackRock World Gold Fund
CAGR/Annualized return of 2% since its launch. Ranked 11 in Global category. Return for 2021 was -9% , 2020 was 31.4% and 2019 was 35.1% . DSP BlackRock World Gold Fund
Growth Launch Date 14 Sep 07 NAV (03 Oct 22) ₹13.4327 ↑ 0.36 (2.73 %) Net Assets (Cr) ₹655 on 31 Aug 22 Category Equity - Global AMC DSP BlackRock Invmt Managers Pvt. Ltd. Rating ☆☆☆ Risk High Expense Ratio 1.38 Sharpe Ratio -1.02 Information Ratio 0.02 Alpha Ratio -8.84 Min Investment 1,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 17 ₹10,000 30 Sep 18 ₹8,402 30 Sep 19 ₹11,105 30 Sep 20 ₹16,454 30 Sep 21 ₹12,756 30 Sep 22 ₹10,541 Returns for DSP BlackRock World Gold Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Oct 22 Duration Returns 1 Month 5% 3 Month -5.3% 6 Month -29.5% 1 Year -15.2% 3 Year -1% 5 Year 1.5% 10 Year 15 Year Since launch 2% Historical performance (Yearly) on absolute basis
Year Returns 2021 -9% 2020 31.4% 2019 35.1% 2018 -10.7% 2017 -4% 2016 52.7% 2015 -18.5% 2014 -3% 2013 -41.5% 2012 -5.8% Fund Manager information for DSP BlackRock World Gold Fund
Name Since Tenure Jay Kothari 1 Mar 13 9.51 Yr. Data below for DSP BlackRock World Gold Fund as on 31 Aug 22
Equity Sector Allocation
Sector Value Basic Materials 95.06% Asset Allocation
Asset Class Value Cash 2.56% Equity 95.06% Debt 0% Other 2.38% Top Securities Holdings / Portfolio
Name Holding Value Quantity BGF World Gold I2
Investment Fund | -99% ₹649 Cr 2,652,963 Treps / Reverse Repo Investments / Corporate Debt Repo
CBLO/Reverse Repo | -3% ₹21 Cr Net Receivables/Payables
Net Current Assets | -2% -₹15 Cr 3. Nippon India Pharma Fund
CAGR/Annualized return of 20.1% since its launch. Ranked 35 in Sectoral category. Return for 2021 was 23.9% , 2020 was 66.4% and 2019 was 1.7% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (04 Oct 22) ₹287.81 ↑ 2.66 (0.93 %) Net Assets (Cr) ₹4,588 on 31 Aug 22 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 0.96 Sharpe Ratio -1.11 Information Ratio 0.68 Alpha Ratio -0.79 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 17 ₹10,000 30 Sep 18 ₹12,287 30 Sep 19 ₹10,893 30 Sep 20 ₹17,507 30 Sep 21 ₹23,883 30 Sep 22 ₹21,908 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Oct 22 Duration Returns 1 Month 5% 3 Month 9.6% 6 Month -2.3% 1 Year -8.9% 3 Year 27.5% 5 Year 17.2% 10 Year 15 Year Since launch 20.1% Historical performance (Yearly) on absolute basis
Year Returns 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% 2014 49.5% 2013 20.9% 2012 34.8% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 17.43 Yr. Kinjal Desai 25 May 18 4.27 Yr. Data below for Nippon India Pharma Fund as on 31 Aug 22
Equity Sector Allocation
Sector Value Health Care 99.69% Asset Allocation
Asset Class Value Cash 0.31% Equity 99.69% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA14% ₹652 Cr 7,300,976 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000879% ₹415 Cr 4,000,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | 5001248% ₹361 Cr 850,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002577% ₹301 Cr 4,500,025
↑ 200,000 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Sep 20 | TORNTPHARM6% ₹295 Cr 1,900,000
↓ -56,932 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹272 Cr 750,000
↓ -150,985 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 30 Jun 17 | NH6% ₹259 Cr 3,701,313
↓ -327,779 Abbott India Ltd (Healthcare)
Equity, Since 31 May 11 | 5004885% ₹242 Cr 129,321 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMA4% ₹191 Cr 3,500,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Aug 18 | 5328434% ₹177 Cr 6,000,000
↓ -500,000 4. HDFC Long Term Advantage Fund
CAGR/Annualized return of 21.4% since its launch. Ranked 23 in ELSS category. . HDFC Long Term Advantage Fund
Growth Launch Date 2 Jan 01 NAV (14 Jan 22) ₹595.168 ↑ 0.28 (0.05 %) Net Assets (Cr) ₹1,318 on 30 Nov 21 Category Equity - ELSS AMC HDFC Asset Management Company Limited Rating ☆☆☆ Risk Moderately High Expense Ratio 2.25 Sharpe Ratio 2.27 Information Ratio -0.15 Alpha Ratio 1.75 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 30 Sep 17 ₹10,000 30 Sep 18 ₹10,744 30 Sep 19 ₹11,412 30 Sep 20 ₹10,757 30 Sep 21 ₹17,891
Purchase not allowed Returns for HDFC Long Term Advantage Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Oct 22 Duration Returns 1 Month 4.4% 3 Month 1.2% 6 Month 15.4% 1 Year 35.5% 3 Year 20.6% 5 Year 17.4% 10 Year 15 Year Since launch 21.4% Historical performance (Yearly) on absolute basis
Year Returns 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Fund Manager information for HDFC Long Term Advantage Fund
Name Since Tenure Data below for HDFC Long Term Advantage Fund as on 30 Nov 21
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 5. Motilal Oswal Midcap 30 Fund
CAGR/Annualized return of 21% since its launch. Ranked 27 in Mid Cap category. Return for 2021 was 55.8% , 2020 was 9.3% and 2019 was 9.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (04 Oct 22) ₹51.5724 ↑ 0.77 (1.52 %) Net Assets (Cr) ₹3,158 on 31 Aug 22 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 1.51 Sharpe Ratio 1.17 Information Ratio -0.15 Alpha Ratio 12.47 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Sep 17 ₹10,000 30 Sep 18 ₹9,555 30 Sep 19 ₹10,242 30 Sep 20 ₹9,963 30 Sep 21 ₹16,708 30 Sep 22 ₹20,554 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 4 Oct 22 Duration Returns 1 Month 4.2% 3 Month 21.8% 6 Month 14.3% 1 Year 21.5% 3 Year 27.5% 5 Year 15.3% 10 Year 15 Year Since launch 21% Historical performance (Yearly) on absolute basis
Year Returns 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% 2014 2013 2012 Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Abhiroop Mukherjee 24 Feb 14 8.52 Yr. Niket Shah 1 Jul 20 2.17 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 Aug 22
Equity Sector Allocation
Sector Value Consumer Cyclical 27.25% Financial Services 18.33% Industrials 13.87% Real Estate 10.47% Utility 8.22% Basic Materials 7.45% Health Care 3.86% Asset Allocation
Asset Class Value Cash 10.57% Equity 89.43% Top Securities Holdings / Portfolio
Name Holding Value Quantity Tube Investments of India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Jul 20 | 54076212% ₹388 Cr 1,715,000 Phoenix Mills Ltd (Real Estate)
Equity, Since 30 Apr 20 | 50310010% ₹302 Cr 2,150,000
↑ 150,000 Gujarat Gas Ltd (Utilities)
Equity, Since 30 Sep 21 | 5393368% ₹259 Cr 5,500,000
↑ 225,000 Campus Activewear Ltd (Consumer Cyclical)
Equity, Since 30 Apr 22 | 5435238% ₹252 Cr 5,100,000
↓ -140,000 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Mar 21 | 5000937% ₹236 Cr 10,500,000 Bajaj Finance Ltd (Financial Services)
Equity, Since 30 Sep 16 | 5000345% ₹157 Cr 215,000
↑ 50,000 Voltas Ltd (Industrials)
Equity, Since 31 Oct 17 | VOLTAS5% ₹150 Cr 1,500,000 AU Small Finance Bank Ltd (Financial Services)
Equity, Since 31 Jul 17 | 5406115% ₹148 Cr 2,335,000 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 30 Jun 18 | CHOLAFIN4% ₹138 Cr 1,750,000 Barbeque-Nation Hospitality Ltd (Consumer Cyclical)
Equity, Since 28 Feb 22 | 5432834% ₹113 Cr 995,212
↓ -4,788
How to Invest in Best Mutual Funds Online?
Open Free Investment Account for Lifetime at Fincash.com.
Complete your Registration and KYC Process
Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest!
Smart Tips to Invest in Best Mutual Funds: Lump Sum & SIP Investments
A perfect way to invest in the best performing mutual funds is by looking at both its qualitative and quantitative measures, such as:
1. Scheme Asset Size
Investors should always go for a fund that is neither too big nor too small in size. While there is no perfect definition and relation between the size of the fund, it is said that both too small or too large, can hinder a fund’s performance. Less Asset Under Management ( AUM) in any scheme is very risky as you don't know who the investors are & what quantum of investments they have in a particular scheme. Thus, while choosing a fund, it is advisable to go for the one whose AUM is approximately the same as the category.
2. Fund Performance
To invest in the best performing mutual funds, the investors should do a fair assessment of the fund's performances for over a period of time. Also, it is suggested to go for a scheme that consistently beats its benchmark over 4-5 years, additionally, one should see each period to check if the fund is able to beat the benchmark.
3. Total Expense Ratio
Investors who want to make investments in mutual funds have to bear certain charges like management fees, operation costs, etc., charged by the Asset Management Company (AMC). Many times, investors go for a fund that has a lower expense ratio, but it is something that should not supersede other important factors such as fund performance, etc.
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2022 Shepard Technologies Private Limited. All Rights Reserved
Excellent Very helpful for seclecting top most mutual funds for Investment
Very in-depth and unbiased analysis useful for evaluation of MF performance and prospects.
very helpful
Want to know about MF